Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry 'Revision: v3.5.4' was added to the Record History and the previous entry 'Revision: v3.5.3' was removed. This reflects an update to the page version history rather than changes to the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew revision v3.5.3 was added to the record history and the previous revision v3.5.2 was removed from the list. This update reflects ongoing maintenance of the study record's version history within the ClinicalTrials.gov workflow.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry (v3.5.0) was added to the record history, and the previous revision (v3.4.3) was removed. This updates the versioning history shown on the study record.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check93 days agoChange DetectedA new revision (v3.4.2) was added to the study record history; the previous revision (v3.4.1) was removed along with its associated notice.SummaryDifference0.8%

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.